Azoles and Echinocandins Drug Classes are in the Forefront of the Global Antifungal Drugs Market | Global industry Size, Share, Trend and Forecast until 2025

AnalystView Market Insights recently introduced professional in-depth market research report on antifungal drugs market which is available for immediate purchase. The global antifungal drugs market is expected to grow at growth rate of 1.9% to reach USD 13.8 billion by 2025. Global Antifungal drugs market study provides company profile for Pfizer, Inc., Novartis AG, Sanofi-Aventis, Merck, Bayer AG, and GlaxoSmithKline based on attributes such as company overview, SWOT analysis, strategy benchmarking and key developments.

This study focuses on the market status, growth projection, key players’ revenue share, drivers, restraints and opportunities with respect to the global anti-fungal drugs market. This published report studies global market in terms of types and indications. Also, geographies such as North America, Europe, Asia Pacific, Middle East, and Africa and Latin America are studied in detail.

Fungi are recognized as a major problem for respiratory conditions and symptoms in COPD, asthma, and bronchiectasis patients. Favorable government initiatives would in turn surge in demand for antifungals, leading to drive the market growth. For instance, in January 2015, company named Scynexis, Inc. received U.S. FDA fast track designation for the SCY-078 (oral formulation) for the invasive fungal infections treatment. Such approvals will drive the market growth to great extent. Also, the market for antifungal drugs will undoubtedly increase over the coming few years owing to the surge in demand/utilization of antifungal drugs increase at constant rate over the coming few years.

Get access to exclusive PDF brochure of this study @
www.analystviewmarketinsights.com/request_sample/av106/

Sale of many established as well as some new antifungal drugs touch peak revenue which shows the potential growth of the market. For example, established agent fluconazole and terbinafine had achieved peak revenue in excess of USD 1 billion. Peak revenue of of voriconazole recorded USD 800 million, itraconazole was around USD 900 million and similarly caspofungin was about USD 600 million. This increase in the drug sale will significantly boost the market to great extent.

One of the other factors aiding the spread of these diseases was to rising number of patient population susceptible to fungal infections. For example, according to the Centre for Disease Control and Prevention, fungal infection cause substantial morbidity and mortality among patients. Currently, antifungals drugs represent more than 7% of the global anti-infective market and with around 20% annual growth which is anticipated to cross over USD 15 billion in value after some years. However, in contrast to antibacterials, there are very limited number of antifungal drugs available commercially which would hamper the market growth to some extent.

Antifungal drugs are divided in terms of Azoles, Echinocandins, Polyenes, Allylamines and others. Echinocandins is the highest growing drug class in antifungal treatment, with 4.2% CAGR during the forecast period. In terms of indication, the market divided as Dermatophytosis, Aspergillosis, Candidiasis and Others. Candidiasis segment hold largest revenue and is expected to maintain its dominant position in future. Regionally, the market analyzed in terms of North America, Europe, Asia Pacific, Latin America and Middle East and Africa. Developed regions accounted for the largest share owing to the rise in research and development activities in this area. North America (U.S.) recorded almost 35% share of the total market in 2016.

Key companies such as Pfizer, Inc., Novartis AG, Sanofi-Aventis, Merck, Bayer AG, and GlaxoSmithKline exhibit their potential in this market. Extensive research and development activities coupled with new product approval helped these companies to record significant revenue share of the global market.

Click here to obtain more highlight on “Antifungal Drugs Market, By Types, By Indication, and Geography – Analysis, Share, Trends, Size, & Forecast From 2014 – 2025” study @
www.analystviewmarketinsights.com/report-highlight-antifungal-drugs-market-106/

The global anti-fungal drugs market is segmented on the basis of:

Market, by Types
- Azoles
- Echinocandins
- Polyenes
- Allylamines
- Others

Market, by Indication
- Dermatophytosis
- Aspergillosis
- Candidiasis
- Others

Market, by Region
- North America
- Europe
- Asia Pacific
- Rest of the World

Market, by Country
Further Breakdown of The North America Market
- U.S.
- Canada
Further Breakdown of The Europe Market
- Germany
- France
- Rest of Europe
Further Breakdown of The APAC Market
- India
- China
- Rest of APAC
Further Breakdown of The Rest of the World Market
- Middle East and Africa
- Latin America

Strategic company profiling will be included for below key players:
- Pfizer, Inc.
- Novartis AG
- Sanofi-Aventis
- Merck
- Bayer AG
- GlaxoSmithKline

USP of our key vendor analysis:
Well-designed strategic framework design for these key players will help to understand the market movement including regional expansion, mergers & acquisitions, and new product developments
Thorough SWOT i.e. Strength, Weakness, Opportunities and Threat for individual company profiling is analyzed in order to present a detailed market opportunity assessment.

Key benefits of the report:
• The report presents a macro and micro-level outlook regarding the industry. Thus, it becomes easy for our clients to perceive the business landscape and take a glimpse of their own standing in it.
• A thorough analysis of relevant statistical data to estimate the market paradigms
• Exceptional understanding of region and country-specific markets. The report will answer some of the toughest questions regarding the market shares, sizes, forecasts segmentations, and growth specific to the countries.
• Well-designed strategic framework analyzes the market movements including regional expansion, mergers & acquisitions, and new product developments

Research Methodology:
- Preliminary Data Mining: Secondary Research, Paid Databases, Primary Research
- Data Synthesis & Analysis: Top-Down Approach, Bottom-Up Approach, Supply Side and Demand Side
- Market Formulation: Market Dynamics, Total Addressable Market and Machine Learning Technique
- Data Verification: Quality Assurance and Reach a Conclusion

To enquire more about our research process and report store, please connect @
https://www.analystviewmarketinsights.com/get-in-touch/

About Us
AnalystView Market Insights is a market research and consulting firm that adopts a proactive approach to provide the diverse need for accurate and precise market research, custom research, and consulting solutions across geographies and industry verticals. We strive to develop meaningful and evidence-based research data that helps our clients, empowering organizations and brands of all sizes with strategic analysis, accurate data, and consumer trends for various industries such as Healthcare, Bulk Chemicals, Semiconductors, Electronics, and Foods and Beverages.

Contact Us
Mr. Jose (Press & Marketing Manager)
Corporate Sales, USA
AnalystView Market Insights
Email: sales@analystviewmarketinsights.com
Tel: +91-757-498-5725 (Asia-Pacific Business Centre)
Web: www.analystviewmarketinsights.com

This release was published on openPR.